The prevention of secondary haemorrhage after prostatectomy: the value of antifibrinolytic therapy.
This study examines the effect of antifibrinolytic therapy on the incidence of secondary haemorrhage following endoscopic surgery. One hundred consecutive patients were allocated randomly to treatment and control groups. The incidence of secondary haemorrhage was reduced from 56% in the control group to 24% in the treatment group.
D002986:Clinical Trials as Topic; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D006470:Hemorrhage / Q000517:prevention & control*; D006801:Humans; D008297:Male; D011183:Postoperative Complications / Q000517:prevention & control*; D011468:Prostatectomy; D011897:Random Allocation; D014148:Tranexamic Acid / Q000627:therapeutic use*; D014570:Urologic Diseases / Q000517:prevention & control*
D003509:Cyclohexanecarboxylic Acids; D014148:Tranexamic Acid